GLP-1 receptor agonists prove effective for kidney and cardiovascular outcomes

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes.

Persistent Systems Launches Generative-AI-Powered Population Health Solution

What You Should Know: – Persistent Systems, a leading digital engineering and enterprise modernization company, and Microsoft today announced the launch of an innovative Generative

February 8, 2024

Lexeo brings in $95M; FDA lifts hold on Nurix cancer trial

Plus, news about Ventyx Biosciences, CEPI, Evolus, Recursion and Sensorion: Lexeo Therapeutics raises $95M: The financing is nearly the same size as the gene therapy

March 12, 2024

Fianlimab by Regeneron Pharmaceuticals for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

June 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.